Clinical workflow
G2211 Documentation and wRVU Capture for REI Physicians
Learn how reproductive endocrinologists document G2211 for longitudinal infertility care to capture 0.33 wRVU per eligible E/M visit.
Longitudinal Fertility Care: G2211 Documentation and wRVU Capture for Reproductive Endocrinologists
Merry AI · Thoughtfully curated clinical briefs.
Reproductive endocrinologists can report HCPCS G2211 (an add-on valued at 0.33 wRVU) on office and outpatient E/M visits (99202 to 99215) when the record shows the physician is the continuing focal point for a serious or complex condition such as infertility or recurrent pregnancy loss. The physician does not need to document time. They need to document an ongoing, longitudinal relationship and a plan of care that extends beyond today's encounter.
G2211 recognizes longitudinal complexity, not time. Ongoing infertility management can qualify.
CMS requires no extra template, but the record must show continuing care responsibility.
Merry AI's Clinical Logic Bridge links each visit to the longitudinal fertility plan.
Recovered complexity revenue reaches $15,600+ per provider yearly, at 1.3% of loaded labor.
A $648 tool against a $48,000 labor denominator equals 1.3% cost
CLINICAL UPDATE 2026: Revised for new CMS CPT G2211 standards, SB 1120 compliance, and FHIR interoperability.
Reproductive endocrinology carries a documentation burden that most fee-schedule analyses ignore. Each patient generates monitoring visits, lab reviews, cycle planning, and counseling encounters, and the cost of documenting them sits in the denominator, not the headline payment rate.
A fully loaded medical assistant costs roughly $48,000 per year once wages, benefits, payroll taxes, turnover, and scribe overhead are included. Merry AI Pro costs $648 per year ($54 per month, billed annually).
That ratio frames every decision below. At 1.3% of loaded labor cost, the question is not labor replacement. It is margin recovery on work the physician is already performing but not capturing.
The $15,600+ recovery figure follows simple arithmetic. G2211 pays roughly $16 nationally per eligible visit (locality and the annual conversion factor shift the exact amount), so about 975 qualifying visits per year, or 20 per week, produces $15,600 and roughly 320 additional wRVUs.
Practice benchmarks place documentation savings at 2.1+ hours per provider per day. For a fellowship-trained REI, those hours return to embryo-transfer counseling and complex cycle decisions rather than after-hours charting.
| Line Item | Annual Figure | Notes |
|---|---|---|
| Loaded MA cost | $48,000 | Wages, benefits, turnover included |
| Merry AI Pro | $648 | $54/mo annual; 1.3% of MA denominator |
| Recovered G2211 revenue | $15,600+ | About 975 eligible visits at roughly $16 |
| Added wRVUs | About 320 | 0.33 wRVU per G2211 unit |
| Daily time returned | 2.1+ hours | Per provider |
Compare your specialty cost model against peer practices in the Specialty Clinical Playbook Library.
G2211 attaches to the relationship, while MDM still sets the base code
G2211 does not raise the E/M level, and it does not depend on medical decision making (MDM). The base code (99213, 99214, or 99215) is still selected by MDM or total time, and G2211 is added when the longitudinal relationship is documented.
Payer eligibility must be verified before billing. G2211 is a Medicare code, and commercial and Medicaid adoption varies. In REI, Medicare-eligible patients are often disability-entitled patients of reproductive age or patients with endocrine conditions (primary ovarian insufficiency, PCOS with metabolic disease, hypogonadism), and assisted reproduction itself is frequently excluded from coverage.
| Clinical Scenario | Key Clinical Indicators | Typical MDM Level | G2211 Support | Audit Defense in Record |
|---|---|---|---|---|
| Stable infertility follow-up | Cycle review, ovulation tracking, stable labs | Low (99213) | Yes, if continuing plan documented | Named ongoing plan of care; prior cycle reference |
| PCOS ovulatory dysfunction, medication adjustment | Letrozole dose change, BMI, A1c or glucose trend | Moderate (99214) | Yes | Prescription drug management plus longitudinal endocrine plan |
| Recurrent pregnancy loss evaluation | Loss count, karyotype, antiphospholipid panel, uterine imaging | Moderate to High (99214 or 99215) | Yes | Linkage of workup results to next-cycle strategy |
| Post-failed transfer planning | Embryo grading, endometrial thickness, AMH, antral follicle count | Moderate to High | Yes | Explicit "cycle #3 of ongoing plan" language |
| Same-day procedure with Modifier 25 | Separate E/M plus minor procedure | Any | No (procedure context) | Separate E/M note; G2211 withheld |
| Modifier 25 with preventive service | E/M plus vaccine or Part B preventive service | Any | Yes (2025 CMS exception) | Document preventive service separately |
Human-attested metrics and a documented plan of care defend G2211 audits
A reproductive endocrinologist sees a patient after two failed embryo transfers, with recurrent pregnancy loss and PCOS-related ovulatory dysfunction. The complexity is real, but the note often reads like a single, isolated visit.
Merry AI builds a Clinical Logic Bridge that documents IVF cycle #3 planning and links today's medication changes and embryo-transfer counseling to the longitudinal treatment plan.
The bridge references the recurrent-loss evaluation and endocrine comorbidity management, then flags G2211 support so the practice captures complexity revenue without leaning on generic time-based documentation.
Human-attested clinical metrics anchor the record. AMH values, antral follicle counts, endometrial thickness in millimeters, beta-hCG trends, and loss history are physician-confirmed, never inferred or autocompleted.
California SB 1120 governs payers, not practices. Since January 1, 2025, health plans in California must have a licensed physician or qualified clinician make medical necessity denials, rather than relying on an algorithm alone. Clear, human-attested documentation is exactly what that human reviewer reads.
Modifier 25 is the most common G2211 denial trigger. CMS does not pay G2211 when the E/M is billed with Modifier 25 on the same day as a procedure, but since 2025 it does pay when Modifier 25 accompanies an annual wellness visit, vaccine administration, or a Medicare Part B preventive service.
Reviewers may inspect the medical record to confirm the care relationship. A documented longitudinal plan of care is the defensible artifact. See the CMS G2211 FAQ.
| Risk Vector | Generic Note | Clinical Logic Bridge |
|---|---|---|
| Modifier 25 collision | Unflagged | Pre-submission flag with exception check |
| Payer physician review | AI-inferred values | Human-confirmed metrics |
| Longitudinal linkage | Absent | Cycle-to-cycle thread |
| Complexity support | Time-based only | Relationship-based |
Consistent ICD-10 coding across cycles carries the G2211 longitudinal signal
Diagnosis coding carries the signal that supports G2211. CMS has stated that diagnoses in the claims history can support the existence of the longitudinal care relationship.
Two anchor codes dominate REI continuity: female infertility and recurrent pregnancy loss. Each should thread consistently across cycle visits, with more specific codes used whenever the etiology is known.
| Code | Description | Reference |
|---|---|---|
| N97.9 | Female infertility, unspecified | N97.9 (ICD-10-CM) |
| N96 | Recurrent pregnancy loss | N96 (ICD-10-CM) |
| N97.0 | Female infertility associated with anovulation | Preferred over N97.9 when anovulation is confirmed |
| E28.2 | Polycystic ovarian syndrome | Pairs with N97.0 for PCOS-related infertility |
Consistency across the record matters as much as specificity. The same complex condition, actively managed over time and coded the same way, substantiates the inherent complexity G2211 recognizes.
Supporting literature on recurrent loss and ovulatory dysfunction is indexed through NIH National Library of Medicine Research.
An IVF cycle is a phase within continuous infertility care
The CMS FAQ addresses primary care well. Its examples, such as HIV and sickle cell disease, are obviously continuous chronic conditions. Reproductive endocrinology is the overlooked case.
Most guidance stops at the FAQ's statement that no specific diagnosis is required. It never addresses how a cyclical, episodic specialty proves continuity over time.
Here is the anchor truth. An IVF cycle is not time-limited care. It is a bounded phase within a continuous infertility management relationship that spans multiple cycles, loss evaluations, and endocrine follow-up.
The FAQ excludes discrete, routine, or time-limited relationships. REI practices often fear their episodic cadence disqualifies them. It does not, when the plan of care is documented as ongoing and the REI is the continuing focal point.
The workflow wedge is the thread, not the visit. Merry AI documents each cycle as a continuation, converting perceived episodic care into demonstrable longitudinal responsibility.
This reframing is the information gain: specialty continuity is a documentation architecture problem, not a billing-eligibility problem. Eligibility follows the relationship, and the relationship must be written down.
Merry AI injects notes into existing EHR fields without IT setup
Merry AI operates as a browser-native Chrome extension overlay, injecting structured content directly into existing EHR fields. There is zero IT setup and no server migration.
The DOM overlay works with closed EHR screens that reject conventional integrations. Field injection places the Clinical Logic Bridge where the note already lives, so the record of truth stays in the EHR.
Fertility programs running group sessions (injection teaching, mind-body support groups, counseling cohorts) benefit from automatic group note-splitting. Shared session content divides into individual, attributable records.
FHIR interoperability is the 2026 backdrop. The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) requires payers to stand up FHIR-based prior authorization APIs by January 2027, which raises the value of structured, consistent clinical data in every note.
| Capability | Conventional | DOM Overlay |
|---|---|---|
| IT setup required | Weeks | None |
| Closed EHR support | Limited | Field injection |
| Group note-splitting | Manual | Automatic |
| Data residency | Vendor server | Existing EHR |
Confirm your platform compatibility through the EHR Clinical Integration Directory.
Three-phase orchestration keeps every fertility visit tied to the longitudinal record
The intelligence layer orchestrates the visit across three phases: before, during, and after. Each phase reinforces the longitudinal record G2211 depends on.
Pre-visit automation surfaces prior cycle data, loss evaluations, and open plan-of-care items. The clinician enters the room with the thread already assembled.
During the visit, structured capture runs alongside the conversation. Human-attested metrics are confirmed by the physician, not autocompleted, preserving the attestation posture.
Post-visit, the Clinical Logic Bridge finalizes, flags G2211 support or a Modifier 25 conflict, and injects the record. Closed-pilot orchestration keeps this bounded and auditable.
| Phase | Action | Output |
|---|---|---|
| Pre-visit | Surface cycle history | Assembled thread |
| During visit | Confirm clinical metrics | Attested record |
| Post-visit | Finalize Logic Bridge | G2211 flag and EHR injection |
Five documentation elements make an REI note G2211-ready
Use this checklist before signing any established-patient E/M note where G2211 is intended.
- Named longitudinal condition: infertility, recurrent pregnancy loss, or a related endocrine disorder.
- Continuing focal point statement: the REI is managing the condition over time.
- Prior-cycle reference: outcomes from earlier cycles or evaluations that inform today's plan.
- Forward plan of care: next cycle, next labs, or next follow-up interval.
- Modifier 25 check: no same-day procedure, or a qualifying preventive-service exception.
Frequently asked questions about G2211 in reproductive endocrinology
G2211 applies to REI visits when the relationship is ongoing
Specialists qualify, not just primary care. CMS allows G2211 when a specialist provides ongoing care for a single serious or complex condition, which fits active infertility and recurrent loss management.
G2211 adds 0.33 wRVU to each eligible visit
The add-on is valued at 0.33 work RVU, paying roughly $16 nationally, with exact payment varying by locality and conversion factor.
New patient visits can carry G2211 when ongoing care begins
CMS permits G2211 on new patient visits (99202 to 99205) when the visit establishes a relationship the physician intends to continue, so a consultation-only visit should not carry it.
Commercial payer adoption of G2211 must be verified individually
G2211 is a Medicare code. Confirm each commercial and Medicaid contract before billing, since fertility benefits and code recognition vary widely by plan and state.
See plan options for your practice in Merry AI Practice Partner Plans, starting at $54 per month billed annually.